- Home
- ROIV vs TRMB Comparison
ROIV vs TRMB Comparison
Compare ROIV & TRMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ROIV | TRMB |
|---|---|---|
| Founded | 2014 | 1978 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.6B | 19.2B |
| IPO Year | N/A | 1990 |
Fundamental Metrics
Financial Performance| Metric | ROIV | TRMB |
|---|---|---|
| Price | $26.32 | $66.46 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 7 |
| Target Price | $27.44 | ★ $94.43 |
| AVG Volume (30 Days) | ★ 6.9M | 2.8M |
| Earning Date | 02-06-2026 | 02-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.76 |
| Revenue | $13,310,000.00 | ★ $3,587,300,000.00 |
| Revenue This Year | N/A | $8.97 |
| Revenue Next Year | $741.42 | $8.39 |
| P/E Ratio | ★ N/A | $37.73 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.73 | $52.91 |
| 52 Week High | $27.94 | $87.50 |
Technical Indicators
Market Signals| Indicator | ROIV | TRMB |
|---|---|---|
| Relative Strength Index (RSI) | 66.81 | 37.51 |
| Support Level | $26.31 | $64.41 |
| Resistance Level | $27.94 | $69.23 |
| Average True Range (ATR) | 0.97 | 2.30 |
| MACD | 0.46 | 0.18 |
| Stochastic Oscillator | 79.45 | 31.52 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About TRMB Trimble Inc.
Trimble Inc is a technology solutions provider that enables office and mobile professionals to connect their workflows and asset lifecycles to drive a more productive, sustainable future. The company has three reportable segments: Architects, Engineers, Construction, and Owners (AECO). This segment provides software solutions that sell through a direct channel to customers in the construction industry. Field Systems. This segment provides hardware and associated software solutions that sell through dealer partner channels. Transportation and Logistics (T&L). This segment provides solutions for customers working in long-haul trucking and freight shipping markets.